Market Cap 133.19M
Revenue (ttm) 32.38M
Net Income (ttm) -21.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -66.83%
Debt to Equity Ratio 0.00
Volume 414,500
Avg Vol 866,010
Day's Range N/A - N/A
Shares Out 97.93M
Stochastic %K 75%
Beta 1.37
Analysts Strong Sell
Price Target $4.12

Company Profile

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed t...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 314 678 6100
Address:
710 North Tucker Boulevard, Suite 110, Saint Louis, United States
DecoderRing
DecoderRing Aug. 7 at 7:34 PM
$STXS Additional love note for David: Please expand on prior trials performed with Stereotaxis that addressed pulmonary artery denervation (PADN). There was a 50 patient randomized sham-controlled study that hit a p val of .001 where residual chronic thromboembolic pulmonary hypertension was the endpoint (PVR reduction). This was followed up by a larger PADN multi-center trial with 128 patients with WHO group 1 - PADN + PDE-5 inhibitor and sham. P < 0.001 with improvements in : pulmonary vascular resistance right ventricular function tricuspid regurgitation NT-proBNP clinical worsening Clinical worsening was 1.6% vs. 13.8% during follow-up. https://www.jacc.org/doi/10.1016/j.jcin.2022.09.013?utm_source=chatgpt.com
0 · Reply
DecoderRing
DecoderRing Aug. 7 at 7:23 PM
$STXS In case management reads here and has plans to sleepwalk through the earnings call, here are some things you could talk about that are actually exciting: Has the 500-patient CHANGE registry actually completed enrollment? When will the R-One PCI data be released? What were the results of the R-One 5G tele-PCI study? How many R-One systems are currently installed? How many PCI procedures are being performed per month? What exactly did Robocath accomplish in the R-Star first-in-human study? When does Stereotaxis expect to begin the U.S. R-Star clinical program? Is the carotid/neurointerventional program going into a formal clinical trial? How far along is EMAGIN? Can Synchrony/SynX actually enable remote procedures with the Robocath platform?
0 · Reply
brunoq14
brunoq14 Aug. 7 at 6:29 PM
$STXS Estimated revenue on Yahoo Finance is $8.35M. Estimated earnings is (.05), with a high estimate of (.03).
0 · Reply
Georges8792
Georges8792 Aug. 7 at 1:17 PM
$STXS Even Avita is flying 😂😂😂
0 · Reply
alexpitti
alexpitti Aug. 7 at 12:52 PM
interest rates are falling and growth is slowing. this is good news for our stocks $MIST $STXS $DCTH $ABEO
0 · Reply
RAClose
RAClose Aug. 7 at 1:18 AM
$STXS Today I heard of this company via Ross Givens, he posted a review on his Youtube. Facinating tech, and it seems more are learning about it. I'm watching this closely now. Heres the video. https://www.youtube.com/watch?v=kF8HPlAMYD0
0 · Reply
jacksonjohn750
jacksonjohn750 Aug. 6 at 4:14 PM
$STXS This will move after the next dilution
0 · Reply
Stonksman16
Stonksman16 Aug. 6 at 1:40 PM
$STXS definitely the most depressing stock in my portfolio
1 · Reply
alexpitti
alexpitti Aug. 5 at 5:58 PM
really the supply problems were all of 2025, we just didn't know about it. they stopped production in q1 26 to fix it. now it's basically fixed and needs to scale a bit more $STXS
1 · Reply
alexpitti
alexpitti Aug. 5 at 4:05 PM
people talk a lot of bullshit about how $STXS can't get genesisx orders because they don't have enough magic catheters produced. however, that's not true. say a hospital makes an order for a genesisx in july. then it gets installed a couple months later. maybe some training goes on and probably q4 we see it going full blast. by that time stereotaxis will nearly be at 500 per month. they can shift the supply to the new systems. the old systems can use the microport catheter or older jnj catheters. magic production won't be a limiting factor. we are talking about getting 2 or 3 genesisx orders. it's not a substantial number. it would be a problem if we wanted 10 orders, but that's not until 2027
1 · Reply
Latest News on STXS
Stereotaxis Registration statement: Registration filing

Jul 15, 2026, 8:00 AM EDT - 23 days ago

Stereotaxis Registration statement: Registration filing


Stereotaxis Registration statement: Registration filing

Jul 15, 2026, 8:00 AM EDT - 23 days ago

Stereotaxis Registration statement: Registration filing


Stereotaxis Completes Acquisition of Robocath

Jul 9, 2026, 8:08 AM EDT - 4 weeks ago

Stereotaxis Completes Acquisition of Robocath


Stereotaxis management to meet with BTIG

2026-07-01T20:10:17.000Z - 5 weeks ago

Stereotaxis management to meet with BTIG


Stereotaxis Slides: Investor presentation

Jun 23, 2026, 7:00 AM EDT - 6 weeks ago

Stereotaxis Slides: Investor presentation


Stereotaxis Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 3 months ago

Stereotaxis Earnings Call Transcript: Q1 2026


Stereotaxis Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 3 months ago

Stereotaxis Earnings release: Q1 2026


Stereotaxis Quarterly report: Q1 2026

May 12, 2026, 4:30 PM EDT - 3 months ago

Stereotaxis Quarterly report: Q1 2026


Stereotaxis Transcript: M&A announcement

Apr 15, 2026, 9:00 AM EDT - 4 months ago

Stereotaxis Transcript: M&A announcement


Stereotaxis Press release: M&A announcement

Apr 15, 2026, 9:00 AM EDT - 4 months ago

Stereotaxis Press release: M&A announcement


Stereotaxis to acquire Robocath, terms undisclosed

2026-04-15T11:12:19.000Z - 4 months ago

Stereotaxis to acquire Robocath, terms undisclosed


Stereotaxis Announces Definitive Agreement to Acquire Robocath

Apr 15, 2026, 7:00 AM EDT - 4 months ago

Stereotaxis Announces Definitive Agreement to Acquire Robocath


Stereotaxis receives FDA clearance for Synchrony system

2026-04-06T12:40:34.000Z - 4 months ago

Stereotaxis receives FDA clearance for Synchrony system


Stereotaxis Proxy statement: Proxy filing

Apr 3, 2026, 8:00 AM EDT - 4 months ago

Stereotaxis Proxy statement: Proxy filing


Stereotaxis Proxy statement: Proxy filing

Apr 3, 2026, 8:00 AM EDT - 4 months ago

Stereotaxis Proxy statement: Proxy filing


Stereotaxis files $100M mixed securities shelf

2026-03-13T20:30:19.000Z - 5 months ago

Stereotaxis files $100M mixed securities shelf


Stereotaxis management to meet virtually with BTIG

2026-03-13T19:35:41.000Z - 5 months ago

Stereotaxis management to meet virtually with BTIG


Stereotaxis Registration statement: Registration Filing

Mar 13, 2026, 8:00 AM EDT - 5 months ago

Stereotaxis Registration statement: Registration Filing


Stereotaxis Earnings Call Transcript: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 5 months ago

Stereotaxis Earnings Call Transcript: Q4 2025


Stereotaxis Annual report: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 5 months ago

Stereotaxis Annual report: Q4 2025


Stereotaxis Earnings release: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 5 months ago

Stereotaxis Earnings release: Q4 2025


Stereotaxis reports Q4 EPS (6c), consensus (6c)

2026-03-09T20:05:19.000Z - 5 months ago

Stereotaxis reports Q4 EPS (6c), consensus (6c)


Stereotaxis sees FY26 revenue up double digits

2026-03-09T20:05:10.000Z - 5 months ago

Stereotaxis sees FY26 revenue up double digits


Stereotaxis Reports 2025 Full Year Financial Results

Mar 9, 2026, 4:01 PM EDT - 5 months ago

Stereotaxis Reports 2025 Full Year Financial Results


Stereotaxis reports FDA approval for MAGiC Ablation Catheter

2026-01-06T13:39:16.000Z - 7 months ago

Stereotaxis reports FDA approval for MAGiC Ablation Catheter


Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

Jan 6, 2026, 8:01 AM EST - 7 months ago

Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter


Stereotaxis initiated with an Outperform at Citizens

2025-12-16T09:40:34.000Z - 8 months ago

Stereotaxis initiated with an Outperform at Citizens


Stereotaxis Earnings Call Transcript: Q3 2025

Nov 11, 2025, 4:30 PM EST - 9 months ago

Stereotaxis Earnings Call Transcript: Q3 2025


Stereotaxis Quarterly report: Q3 2025

Nov 11, 2025, 4:30 PM EST - 9 months ago

Stereotaxis Quarterly report: Q3 2025


Stereotaxis Earnings release: Q3 2025

Nov 11, 2025, 4:30 PM EST - 9 months ago

Stereotaxis Earnings release: Q3 2025


Stereotaxis reports Q3 EPS (7c), consensus (6c)

2025-11-11T21:05:25.000Z - 9 months ago

Stereotaxis reports Q3 EPS (7c), consensus (6c)


Stereotaxis Reports 2025 Third Quarter Financial Results

Nov 11, 2025, 4:01 PM EST - 9 months ago

Stereotaxis Reports 2025 Third Quarter Financial Results


Stereotaxis announces FDA clearance for GenesisX

2025-11-10T22:01:01.000Z - 9 months ago

Stereotaxis announces FDA clearance for GenesisX


Stereotaxis resumed with a Buy at Roth Capital

2025-11-05T09:25:11.000Z - 9 months ago

Stereotaxis resumed with a Buy at Roth Capital


Stereotaxis to Present at Upcoming Investor Conferences

Sep 2, 2025, 7:51 AM EDT - 1 year ago

Stereotaxis to Present at Upcoming Investor Conferences


Stereotaxis Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Earnings Call Transcript: Q2 2025


Stereotaxis Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Quarterly report: Q2 2025


Stereotaxis Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Earnings release: Q2 2025


Stereotaxis Reports 2025 Second Quarter Financial Results

Aug 7, 2025, 4:01 PM EDT - 1 year ago

Stereotaxis Reports 2025 Second Quarter Financial Results


Stereotaxis Earnings Call Transcript: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Earnings Call Transcript: Q1 2025


Stereotaxis Quarterly report: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Quarterly report: Q1 2025


Stereotaxis Earnings release: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Earnings release: Q1 2025


Stereotaxis Reports 2025 First Quarter Financial Results

May 12, 2025, 4:01 PM EDT - 1 year ago

Stereotaxis Reports 2025 First Quarter Financial Results


Stereotaxis Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis Proxy statement: Proxy Filing


Stereotaxis Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis Proxy statement: Proxy Filing


Stereotaxis to Present at 37th Annual Roth Conference

Mar 10, 2025, 8:02 AM EDT - 1 year ago

Stereotaxis to Present at 37th Annual Roth Conference


Stereotaxis Earnings Call Transcript: Q4 2024

Mar 3, 2025, 8:30 AM EST - 1 year ago

Stereotaxis Earnings Call Transcript: Q4 2024


Stereotaxis Annual report: Q4 2024

Mar 3, 2025, 8:30 AM EST - 1 year ago

Stereotaxis Annual report: Q4 2024


Stereotaxis Earnings release: Q4 2024

Mar 3, 2025, 8:30 AM EST - 1 year ago

Stereotaxis Earnings release: Q4 2024


Stereotaxis Reports 2024 Full Year Financial Results

Mar 3, 2025, 7:30 AM EST - 1 year ago

Stereotaxis Reports 2024 Full Year Financial Results


Stereotaxis Announces First GenesisX Robotic System Order

Jan 30, 2025, 8:09 AM EST - 1 year ago

Stereotaxis Announces First GenesisX Robotic System Order


Stereotaxis Earnings Call Transcript: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Stereotaxis Earnings Call Transcript: Q3 2024


Stereotaxis Quarterly report: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Stereotaxis Quarterly report: Q3 2024


Stereotaxis Earnings release: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Stereotaxis Earnings release: Q3 2024


Stereotaxis Reports 2024 Third Quarter Financial Results

Nov 11, 2024, 4:02 PM EST - 1 year ago

Stereotaxis Reports 2024 Third Quarter Financial Results


Stereotaxis Registration statement: Registration Filing

Sep 6, 2024, 8:00 AM EDT - 2 years ago

Stereotaxis Registration statement: Registration Filing


Stereotaxis Registration statement: Registration Filing

Aug 23, 2024, 8:00 AM EDT - 2 years ago

Stereotaxis Registration statement: Registration Filing


Stereotaxis Earnings Call Transcript: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Stereotaxis Earnings Call Transcript: Q2 2024


Stereotaxis Quarterly report: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Stereotaxis Quarterly report: Q2 2024


Stereotaxis Earnings release: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Stereotaxis Earnings release: Q2 2024


Stereotaxis Reports 2024 Second Quarter Financial Results

Aug 12, 2024, 4:05 PM EDT - 2 years ago

Stereotaxis Reports 2024 Second Quarter Financial Results


DecoderRing
DecoderRing Aug. 7 at 7:34 PM
$STXS Additional love note for David: Please expand on prior trials performed with Stereotaxis that addressed pulmonary artery denervation (PADN). There was a 50 patient randomized sham-controlled study that hit a p val of .001 where residual chronic thromboembolic pulmonary hypertension was the endpoint (PVR reduction). This was followed up by a larger PADN multi-center trial with 128 patients with WHO group 1 - PADN + PDE-5 inhibitor and sham. P < 0.001 with improvements in : pulmonary vascular resistance right ventricular function tricuspid regurgitation NT-proBNP clinical worsening Clinical worsening was 1.6% vs. 13.8% during follow-up. https://www.jacc.org/doi/10.1016/j.jcin.2022.09.013?utm_source=chatgpt.com
0 · Reply
DecoderRing
DecoderRing Aug. 7 at 7:23 PM
$STXS In case management reads here and has plans to sleepwalk through the earnings call, here are some things you could talk about that are actually exciting: Has the 500-patient CHANGE registry actually completed enrollment? When will the R-One PCI data be released? What were the results of the R-One 5G tele-PCI study? How many R-One systems are currently installed? How many PCI procedures are being performed per month? What exactly did Robocath accomplish in the R-Star first-in-human study? When does Stereotaxis expect to begin the U.S. R-Star clinical program? Is the carotid/neurointerventional program going into a formal clinical trial? How far along is EMAGIN? Can Synchrony/SynX actually enable remote procedures with the Robocath platform?
0 · Reply
brunoq14
brunoq14 Aug. 7 at 6:29 PM
$STXS Estimated revenue on Yahoo Finance is $8.35M. Estimated earnings is (.05), with a high estimate of (.03).
0 · Reply
Georges8792
Georges8792 Aug. 7 at 1:17 PM
$STXS Even Avita is flying 😂😂😂
0 · Reply
alexpitti
alexpitti Aug. 7 at 12:52 PM
interest rates are falling and growth is slowing. this is good news for our stocks $MIST $STXS $DCTH $ABEO
0 · Reply
RAClose
RAClose Aug. 7 at 1:18 AM
$STXS Today I heard of this company via Ross Givens, he posted a review on his Youtube. Facinating tech, and it seems more are learning about it. I'm watching this closely now. Heres the video. https://www.youtube.com/watch?v=kF8HPlAMYD0
0 · Reply
jacksonjohn750
jacksonjohn750 Aug. 6 at 4:14 PM
$STXS This will move after the next dilution
0 · Reply
Stonksman16
Stonksman16 Aug. 6 at 1:40 PM
$STXS definitely the most depressing stock in my portfolio
1 · Reply
alexpitti
alexpitti Aug. 5 at 5:58 PM
really the supply problems were all of 2025, we just didn't know about it. they stopped production in q1 26 to fix it. now it's basically fixed and needs to scale a bit more $STXS
1 · Reply
alexpitti
alexpitti Aug. 5 at 4:05 PM
people talk a lot of bullshit about how $STXS can't get genesisx orders because they don't have enough magic catheters produced. however, that's not true. say a hospital makes an order for a genesisx in july. then it gets installed a couple months later. maybe some training goes on and probably q4 we see it going full blast. by that time stereotaxis will nearly be at 500 per month. they can shift the supply to the new systems. the old systems can use the microport catheter or older jnj catheters. magic production won't be a limiting factor. we are talking about getting 2 or 3 genesisx orders. it's not a substantial number. it would be a problem if we wanted 10 orders, but that's not until 2027
1 · Reply
_Not_Sure_
_Not_Sure_ Aug. 3 at 7:17 PM
$STXS I’m actually getting an ablation this month 🤣😂😐
2 · Reply
alexpitti
alexpitti Aug. 2 at 11:13 PM
$STXS is an absolute gold mine. the clear leader in endovascular surgery. rasor rasor blade model. nearly all products have been approved
1 · Reply
DecoderRing
DecoderRing Aug. 1 at 11:41 AM
$STXS Looking forward to seeing this break $1.00 to the downside.
0 · Reply
TSLA4theWin
TSLA4theWin Jul. 31 at 4:29 PM
$STXS bought this one today just a few 100 shares could be a good one longer term
1 · Reply
twighttrades1
twighttrades1 Jul. 31 at 2:14 AM
$STXS - bought more today and plan to add- if i see buying… they have products and bottom os in i feel. GLTA
0 · Reply
alexpitti
alexpitti Jul. 30 at 8:51 PM
$STXS web traffic genuinely was strong in june. it's not just off a low base
0 · Reply
alexpitti
alexpitti Jul. 30 at 5:58 PM
$STXS web traffic is up 90% month over month
0 · Reply
jacksonjohn750
jacksonjohn750 Jul. 30 at 3:40 PM
$STXS yes, but to the wrong side... it will continue to make the same move
0 · Reply
Georges8792
Georges8792 Jul. 30 at 3:26 AM
$STXS at least Microport gets some sales https://www.linkedin.com/posts/sabine-ernst-4418b115_thanks-to-everyone-involved-really-looking-share-7488287227848880128-43Ss/?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
alexpitti
alexpitti Jul. 29 at 10:27 PM
$STXS if stereotaxis can get 1-2 new genesisX orders on the call in 2 weeks and say they are on target for 500 magic catheters per month by year end, the stock will rise. what it does in the next few days is irrelevant
0 · Reply
Rockafellar
Rockafellar Jul. 29 at 6:16 PM
$STXS is this making a move finally?
1 · Reply
TheInvOb
TheInvOb Jul. 29 at 1:13 PM
$STXS I just happened to look at the news streamer on Think or Swim for STXS... I see an announcement from 7/20 about an RMN program in Hungary featuring Genesis. Not a single word was mentioned on this board that I can find, even by @alexpitti Since then, the stock has dropped from 1.55 to 1.28... Even when they announce growth, they can't catch a break!
1 · Reply